27 January 2020
Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Portola Pharmaceuticals, Inc. (PTLA) from November 5, 2019 through January 9, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Portola Pharmaceuticals, Inc. investors under the federal securities laws.
